Medical research never stops, with new breakthroughs discovered nearly every month. Scientists constantly work to treat symptoms and to understand the root cause of different medical conditions, how to develop better drugs and how new devices can help the body in amazing ways.
Via Christi Research brings those innovations to Kansas, expanding options for physicians and patients. With 26 years of experience skillfully conducting clinical trials, Via Christi Research is nationally recognized for its work with depression, schizophrenia, HIV, heart conditions, arthritis, seizures and more.
Via Christi Research conducts studies in:
- Acute care
- Alzheimer’s Disease/memory
- Cardiovascular disease
- Critical care
- Cystic fibrosis
- Infectious disease
- Otolaryngology (ear, nose, throat)
Via Christi Research began in 1988 as the Center for Phase I Research in Psychiatry, garnering attention from numerous global pharmaceutical corporations for quality conduct of clinical trials. In 1993 Via Christi Research diversified into HIV trials, and today studies interventions for heart, stroke, epilepsy, arthritis, lung conditions, diabetes, infectious diseases and more. Years of dedicated focus conducting clinical trials have honed our skills, resulting in collaboration with the National Institutes of Health and hundreds of pharmaceutical sponsors and contract research organizations.